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TRITIATED thymidine is well recognised to be a highly specific precursor for
DNA syntbesis in mammalian cells. During the past few years there have beeii a
iiumber ofreports of an inhibition ofincorporation of3H-thyrnidine (3H-TdR) into
the DNA ofmyeloid leukaemic leucocytes, bone marrow cells and ascites tumour
cells in vitro, when these cells had been incubated with this precursor for an hour
or more (Bianebi, Crathorn and Shooter, 1962 ; Rubini, Keller, Eisentraut and
Cronkite, 1962 ; Zajicek, Rosin and Gross, 1962). At this time the reasons for this
inhibition were obscure. Zajicek, Beriistein, Rosin and Gross (1963) reported the
formation ofradioactive thymine in the supernatant of a suspension ofascites cells
incubated for one hour with 3H-TdR. More recently Marsh and Perry (1964a,
1964b) have demonstrated that the supernatant fraction ofhomogenates ofhumaii
leucocytes can degrade 3H-thymidine to thymine and dihydrothymine.
We have examined the relationship of the incorporation of 3H-TdR and 11C-
TdR into the DNA ofleucocytes to the degradation ofthis compound by the ceHs.
A study has also been made of the metabolism by leucocytes of an alternative
DNA precursor tritiated deoxycytidine-5'-monophosphate (3H-dCMP). This
investigation was made to see whetber 3H-dCMP is a more useful DNA precursor
than 3H-TdR when prolonged incubations in the presence of the radioactive label
are required, such as in the analysis of the kinetic pattern of the proliferation of
leukaemic cells in vitro.
MATERIALS AND METHODS
Leucocytesu8pensions.-Peripheral. venous blood was collected intoheparinised
bottles, whicb were stood forapproximately 30 minutes at 37' C. after which time
the red blood cells had sedimented out leaving a leucocyte rich plasma which was
removed. The experiments were carried out witli the cells suspended eitber in
undiluted plasma or in plasma diluted 1/1 v/v with tissue culture medium TC 199
(Glaxo, GreeDford, Middlesex). Leucocytes were obtained from patients with
infectious mononucleosis, myeloid or lymphatic leukaemia and from normal
subjects. The mouse thymocytes were prepared from A2G mice and suspended in
Hanks' solution containing 20 per cent mouse serum.
I8otope8.-Tritiated thymidine (3H-TdR) specific activity 2-3 C/mm and
2_14C-thymidine (14C-TdR) specific activity 30
- 4 mc/mm were obtained from the
Radiochemical Centre, Amersham, Bucks. Tritiated deoxvcvtidine-5'-mono-
phosphate (3H-dCMP) specific activity I c/mm and 2-14C-deoxycytidine-5'-mono-
phospbate (14C-dCMP) specific activity 12 mc/mm were obtained from Seliwarz
Bioresearch Inc., Orangeburg, N.Y.
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Incubationpi-ocedure.-All incubations ofleucocyte suspensioils with the radio-
tive precursors were carried out at 37' C. In the experiments for investigation of
uptake of radioactive precursor into the DNA the precursors were used at a con-
centration of 1-2,ac/ml. In the experiments concerned with the degradation of
the precursors the concentrations varied and are given for each individual experi-
nieiit. For the estimation of uptake ofradioactivity into the DNA of individual
cells by autoradiography samples were removed from the incubation mixtures at
specific times, rapidly cooled, washed with ice cold Hanks' solution and theii
suspended in Hanks' solution at 37' diluted 3 : I v/v with distilled water for 7-10
ininutes. Then the cells were fixed inmethanol/acetic acid 3/1 v/v anddropped on
to ice cold slides. For theinvestigation oftheuptake ofradioactivity into the DNA
as measured by scintillation counting, samples from the incubation mixture were
taken into 2 volumes of methanol and the DNA extracted from the precipitate
formed. Fordegradatioii studies thesamples from the incubation wereagain added
to 2 volumes of methanol and the supernatant obtained from this procedure was
analysed.
Autoradiography.-Usually the cell preparations were stained by the Feulgeii
method before autoradiographs were prepared, but in some cases the developed
autoradiographs were stained through the film with McNeal tetrachrome stain at
pH 6
- 5. Autoradiographs wereprepared with Ilford K5 nuclear research emulsioil
exposed at 5' C. for times varying between 1-7 days. They were developed in
Kodak 19.B developer for 5 minutes, rinsed in tap water and fixed in Kodak acid
fixing salt plus hardeiier for 7 minutes, all processes being carried out at 16' C.
Isolationof DNA.-DNA was isolated from the cells by extraction witb 0
- 5 N
perchloric acid using the method of Kit and Dubbs (1962). The quantity of DNA
was estimated by the method of Burton (1956) and the radioactivity counted in a
Packard Tricarb Liquid Scintillation Spectrometer. The counting vials contained
0-2 ml. perchloric acid solution containing the DNA, 2 ml. Hyamine (I m in
methanol), I ml. ethanol and 10 ml. scintillation fluid. The scintillation fluid con-
sisted of 5 g. 2-5 diphenyl oxazole (PPO) and 0
- 3 g. I
-4-bis-2-(4-methyl-5 phenvl oxazolyl) benzeiie (dimethylPOPOP) dissolved in I litre oftoluene.
Analysis of the degradationproducts
Thymidine and its degradation products were analysed by paper chromato-
graphy after the methods ofFink, Cline, Henderson and Fink (1956). The aqueous methanol supernatants from the incubation samples were chromatographed on
Whatman No. I paper by ascending chromatography using as a solvent the upper layer from a mixture ofethyl acetate : water: formic acid 60: 30: 10. A beaker
coiitaining 20 ml. of the lower phase was placed in the bottom of the tank. Un-
labelled thymidine and thymine (L. Light & Co.) and dihydrothymine (Sigma Chemical Coy.) were added to the paper and the positions ofthymine and thymi- dine ascertained by absorption of ultra violet light at 254 ma using a Hanovaria
Chromatolite. Dihydrothymine was identified by spraying the paper first with I N
NaoH and secondly, after 30 minutes, with Ehrlich's reagent (p-dimethyl amino-
beiizaldehyde in HCI and ethanol); this produced a yellow spot. The spots were
then cut out of the chromatogram and counted in approx. 15 ml. of scintillation
fluid.
In this solveiit system dihydrothvmine and its degradation product # ureido
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identified by ascending chromatography in two other solvent svstems :-sec
butanol : tert butanol : water 42
- 5 : 8
- 5 : 47
- 5 and butanol : water : 0
- 88
ammonia, 60: 30: 10 (Fink, Cline, Henderson and Fink, 1956). The degradation
products ofdCMP were partiaRy identified by 1 dimensional ascending chromato-
graphyusing as a solvent the upperphase from a mixture ofethyl acetate : water :
formic acid 60: 27
- 5: 12
- 5. Complete identification was effectedby 2 dimensional
chromatographv using the same solvent in the first direction and using for the
second direction descending chromatography in tert butanol: water : conc. HCI,
11 : 3: 1. B this method the following compounds could be separated :-dCMP.
deoxyuxidine-monophosphate (dUMP), thymidine monophosphate (TMP), deoxy-
cytidine (CdR), deoxyuridine (UdR), uracil and thymine afl being identified by
their UV absorption. The spots were counted as for the thymidine dearadation
products. A further check on the distribution oftheradioactivity in those samples
containing 14C was made by autoradiography of the chromatograms. 4D
RESULTS
Purity of the radioactive precursor,3.-As high specific activity tritiated com-
pounds are liable toundergoradiolysis (Evans andStanford, 1963) thecompositioii of the precursors used in these experiments were analysed. H ysis
showed the distribution ofradioactivity variedaccording to the sample of3H-TdR
used. The percentage distribution was within the following JiMitS : 3H-TdR
(83-3-58-1), 3H-thymine (12-1-23-7), 3H dihydrothymine (4-6-18-2), for the
total activit in these three compounds. 3H dCMP analysis showed (3H dCMP
84%) 3H-deoxycytidine 3%, and left on origin and not identified 12%. 14C
thymidine was found to be stable having approximately 98% of its radioactivity
on the thymidine spot. In view of the radiolysis of the tritiated compounds zero
timeanalyses were made on thedegradation studies and thechange in the composi- tion of the distribution ofradioactivity calculated in relation to the compositioii ofthe original precursor solution added to the incubation mixtures.
Incorporation of radioactive precur,3or8 into the DNA
Typical examples of the incorporation of 3H-TdR compared with that of
3H-dCMP are shown in Fig. 1. These two experiments show the behaviour of
proliferating leucocytes in a benign disease (IM infectious mononucleosis) and a
malignant disease (AML acute myeloidleukaemia). Table I shows the time course
of increase in the DNA specific activity in the cells incubated with 3H-TdR,
14C-TdR or 3H-dCMP. It will be noticed that the mousethymocytes, which have a
highfrequency ofDNAsynthesising cells showed an almost linearincorporation of
3H-TdR which is in marked contrast with that found in the blood leucocytes. Analysis ofthesupernatantsfrom the variousincubationswith3H-TdR and 14CTdR
shows that there is a variable disappearance of the TdR from the medium (Table II). It will be noticed that in the mouse thymocytes, the same incubations as in
Table I, the rate ofdisappearance ofthethymidine was very slow. Fig. 2 confirms
the observations ofMarsh and Perry (1964b) that normalleucocytes degrade TdR
in vitro and shows the rate ofdegradation of TdR and the corresponding rates of
production ofthymine anddihydrothymine. InFig. 3myeloidleukaemia cellshave
been incubated with 14C-TdR and the incubation prolonged to 4 hours. Under
these conditions there is an almost complete removal of the thymidine from theE. H. COOPER AND J. D. MILTON
TABLE I.-Rate ofIncorporation ofPyrimidine Precursors into DNA
DNA specific activity c.p.m. deoxyribose
f _A..
704
% of the cells
synthesising
DNA Precursor
3-5 3H-TdR
14C-TdR
:'H-dCMP
8-5 3H-TdR
3H-dCMP
7
- 7 3H-TdR
3H-dCMP
3H-TdR
3H-dCMP
I 13-5 3H-TdR
3H-dCMP
12-0 3H-TdR
IIH-dCMP
Duration of incubation in minutes
r. --A- I
15 30 45 90 120 150 240
149 - 201 - 210 208
38 58 60 58
13 37 39
872 1690 1370
173 1355 1580
831 1145 958
185 864 827
196 397 334
51 221 351
830 - 2230 4030
Origin of the
leucocytes
*CML .
im
im
CML
Mouse thymocytes
.
Mouse thymocytes
.
50
688
23
72 235
2300 4330
77 171
CML = chronic myeloid leukaemia. IM = infectious mononucleosis.
* Equal numbersofcells inaliquotsfromthe samebatch ofcells were incubatedwith the precursors.
The number of cells in aliquots from the different batches ofcells were not equal to one another.
TABLE II.-Rates ofDegradation ofThymidine by Leucocytes
Percentage of TdR in
supernatant after
incubation
Duration of incubation in
minutes
15 30 60 90
66 40 16
52 25 10
39 13
45 22 8 5
70 52 23 10
24 9 4
85 73 54 40
60 35 13 6
80 57 32 20
47 26
36 13
60 42
70 49 27 13
90 86
98 98 9),
Type of cells used in the incubations
% cells
Cells/c.mm. synthesising
Disease incubation DNA
Normal 12,000 0.1
Normal 11,000 0.1
CML 70,000 3- 5
CML 20,600 1.0
CML(R) 21,900 0- 5
ALL(R) 10,000 0-i
CLL(R) 8,600 0- 2
ALL(R) 16,000 0- 2
Normal 8,000 0-07
Normal 6,500 0-13
CML 70,000 3- 5
CLL 20,000 0- 2
CLL 42,000 0.1
Mouse thymocytes 8,000 12
93, 159000 13-5
lympho-
Precursor cytes
14C-TdR . 35
37
2
7
40
40
37
17
:'H-TdR 40
31
2
72
80
100
100
CML = chronic myeloid leukaemia. ALL = acute lvmphatic leukaemia.
CLL = chronic lymphatic leukaemia. (R).= in remission.
medium with its virtualreplacement by dihydrothymine. Thereciprocal relation-
ship of the degradation ofthymidine and the incorporation ofthymidine into the
DNA of the ceRs in this experiment is s1fown in Fig. 4.
Since it has been suggested that3H-TdR may have an inhibitory effect on the
DNA synthesis of human leucocytes in vitro (Rubini et al., 1962) an experiment
was made to test thishypothesis. Cells were incubated with3H-TdR until the rate
ofchange in their specific activity had become considerably slowed down. At that
time either 3H-TdR or 3H-dCMP was added to two samples and a third left as ar
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coiitrol. Fig. 5 shows that the addition of further radioactive DNA precursors is
associated with a marked increase in the DNA specific activity as compared with
the control. This would indicate that DNA synthesis had not ceased in the
" inhibited
" cells. A further indication ofthe relative availabilityof3H-TdR and
3H-dCMP as precursors forDNA svnthesis is shown in Table 111. In these experi-
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Fic;. I.-The incorporation of 3H-TdR and 3H-dCMP into the DNA ofleucocytes in infectious
mononucleosis (IM) and acute myeloid leukaemia (AML) in vitro. Eacb 13oint on the graph
is the mean of 100 grain counts over individual cells.
TABLE IIL-Effect8 qf Single and Repeated Doses of Precur,3or on the, DNA
Specific Activity ofInfectiow Mononucleo8i8 Leucocyte8 In Vitro
Percentage
of'eelIs
synthesising Specific activity
Patleiit -No. DNA Precursor Deoxyribose/ml. C.p.m./ml. c.p.m. deoxyribose
I 5-4 3H-TdR (s) 8-0 121437 302
766
327
742
146
201
35
58
74
64
e
3H-TdR jr.
4-8 3H-TdR (s)
3H-TdR (r)
3tj-dCMP (s)
3H-dCMP (r)
I
- 0 3H-TdR (s)
3H-TdR (r)
3H-dCMP (s)
3H-dCMP (r)
7
- 8 5967
8 25 2693
8 4 6256
9
- 37 1367
9
- 45 1896
11
- 85 420
11
- 73 679
11
- 37 839
11
- 17 713
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mentsequal amountsof3H-TdR or3H-dCMP were incubated with the cells, either
withthe totaldose added at thebeginningoftheincubation or a quarter ofthedose
at 0, 1) 2 and 3 hours, the total incubation period being 4 hours. Pre-incubation
of chronicmyeloid leukaemic leucocytes with IH-TdR at the same molarity as the
3H-TdR for 2 hours did not alter the subsequent incorporationof 3H-TdR com-
pared with control cells which did not receive the pre-treatment with IH-TdR.
100
> so
0
60
_j
A
LL
0 40
w
0
<
z
w
20 w
CL
10 50 50 70 90
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FiG. 2.-Thedegradation of14C-thymidineby normalleucocytes in vitro. Analysis ofthe distri-
bution of the radioactivity in the supernatant of the incubation rnixture.
8,000/c.mm. leucocytes incubated with 0-4lic/nil. 14C-TdR.
0 := Thymidine. 0 = Thymine. A = Dihydrothymine.
Analysis of the metabolism of 3H-dCMP
A typical result of the distribution of radioactivity on a two-way chromato-
gram ofthe supernatants from the incubation ofchronic myeloid leukaemia leuco-
cyteswith3H-dCMPis showninFig. 6. Themainpathways ofmetabolism ofdCMP
are shown in Fig. 7. A pattern of degradation similar to that of the myeloid
leukaemia cells has also been found in normal leucocytes, leukaemic leucocytes
from cases in remission and infectious mononucleosis leucocytes. On the other
hand, activechroniclymphaticleukaemicleucocytesexhibitedonlyslightdeaminase
activity and this degradation was absent in mouse thymocytes but in both these
cell systems the phosphorolysis ofdCMP to deoxvcvtidine was active (Table IV).
These two populations oflymphatic cells differed in their DNA synthetic activity,
the chronic lymphatic leukaemia cells having less than I : 1,000 cells synthesisinc- .n707 PYRIMIDINE METABOLISM OF LEUCOCYTES
TABLF, IV.-Percentage Distribution of Radio-Activity in Supernatant 2 IZC 3H-dCMP/Ml.
Duration of incubation in minutes
_A_
---I r
30 60 120
t ---I r- ----N r-
----A-
dCMP CcIR UdR U dCMP CdR UdR U dCMP CdR UdR U
4-0 35-8 43-3 16-8 1-7 18-0 34-1 46-2 0-1 0-7 11-4 87-8
19-5 34-3 36-5 9-4 0-5 25-5 54-8 18-6 0-7 3-0 50-2 45-7
11-0 84-4 3-1 1-5 16-7 73-5 6-8 2-9
8-4 50-7 38-4 12-2 16 41-4 29-3 12-4
No detectable deamination in 90 minutes
Cone./ml.
X 106
12
11.0
15
4
15
Noriinal
c.m.T,.
c.T,.L.
I.M.
I'Wouse thymocytes
dCMP:
CdR
UdR
u
10
5
u
0 1
a
cr-
-j
R
La-
0
w
(D
AS
z
w
. o
w
a.
= deoxycytidine-mono-phosphate.
= deoxycytidine.
= deoxyuridine.
= Uracil.
I.M. = Infectious mononucleosis.
TIME OF INCUBATION IN HOURS
FIG. 3.-The degradation of 14C-thymidine by chronic myeloid leukaemic leucocytes in vitro. Analysis of the distribution ofradioactivity in the supernatant of the incubation mixture.
70,000/c.mm. leucocytes incubated with 0
- 5/tc/ml. 14C-TdR.
0 = Thymidine. 0 = Thymine. A
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DNA, whilst the mousethymocytes contained about 12 per cent ofDNAsynthesis-
ing cells. In none of the supernatants from any of these ceR systems studied was
any deoxyuridine monophosphate, thymidine-monophosphate, thymidine or
thymine detected. Analysis of the DNA isolated from leucocytes incubated with
3H-dCMP showed that both the cytosine and thymine bases were labelled with
tritium, the ratios varying in the different cell samples. The results of these
analyses are shown in Table V.
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FIG. 4.--The relation between the rate ofdestruction ofthe 14C-TdR inFig. 3 and theincorpora-
tion of the 14C-TdR into the DNA of the myeloid leukaemic leucocytes.
0
== DNA specific activity.
A_ Percentage of 14C-TdR remaining in the supernatant of the incubation mixture.
TABLEV.-Ratio ofRadio-Activity in DNA Cytosine and Thymine, Base,8 Following
the Incubation of the Cell,3 with 3H-dCMP
Duration of the incubation
30 minutes 4 hours
C/T C/T
1- 83 0- 95
0- 75 0- 8
0- 65 0- 63
3 hours
0- 25
Sample
CML
I.M.
CML
CMLPYRIMIDINE METABOLISM OF LEUCOCYTES 709,
DISCUSSION
The studies ofMarsh andPerry (1964a, 1964b) have clearly demonstrated that
the supernatant fraction (spun at 37,000 x g) from homogenates of normal and
leukaemic leucocytes are able to degrade thymidine to thymine and dihydrothy-
mine. The experiments described in the present paper show the time course of
500
w
tn
0
m
0
w
a
3- 375
z
250
-
w
a- 125 U)
1 2 3 4'j
TiME IN HOURS
FIG. 5.-Effects of the addition of 3H-TdR or 3H-dCMP to suspensions ofmyeloid leukaemic
leucocytes exhibiting an inhibition of the incorporation of 3H-TdR into their DNA.
A .5 Incubations of three samples of chronic myeloid leukaemic cells, 58,000/c.mm. with
I pc/in]. 3H-TdR, the specific activities of the two samples i. were virtually the same.
2,uc/n-A.3H-dCMPaddedtothecultureAafter2-5hoursincubation. I /ZC/Ml.3H-TdRadded to the culture 0 after 2
- 5 hours incubation. 0
= No further addition ofisotope.
this reaction when whole leucocytes are incubated with 3H-thymidine and 14C_
thymidine. The appearance of degradation products in the supernatant of the
incubation mixture occuxred within five minutes ofadding the thymidine. From
the shape of the curve in Fig. 2 it is apparent that this degradation reaction com-
mences immediately and it is not associated with any lag period. This would
indicate that there is a very rapid movement of thymidine and its metabolites
across the cell membrane. When this reaction was studied over a four hourperiod (Fig. 3) it was seen that the rate ofdegradation ofthethymidine wasproportionalE. 11. COOPER AND J. D. MILTON 710
dcmp
.- 75
u
0
io
lx 50
UdR
0
LL
0 uraci'I
w
0
z 25
w
u
cc
w
Q.
CdR
A
TIME IN MINUTES
F.io. 6.-Degradation pattern of 3H-dCMP by chronic myeloid leukaemic leucocytes iii, vitro.
A
= dCMP = deoxycytidine-5'-monophosphate. A -- CdR-deoxvcvtidine.
0
= UdR = deoxyuridine. 0 = Uracil.
CdR
.*-- dCMP UdR P. URACIL
dUMP DNA
k
TMP4----b- TdR 4.-.THYMINE io DIHYDRO-
THYMINE
Fic- 7.-Metabolic inter-relations ofpyrimidine DNA precursors. AfterMaley and Maley (1963).PYRIMIDINE METABOLISM OF LEUCOCYTES 711
to the concentratioii of the thymidine in the medium. In those incubations in
which apart ofthepopulationofcells weresynthesisingDNAthetotalradioactivity
ofthe medium was notsignificantlydecreasedbyincorporation ofradioactivityinto
the DNA.
The similar pattern of results obtained for degradation and incorporation of
thymidineirrespective ofwhether 14C or 3H was used to label the precursor showed
that the degradation of the molecule was not influenced by the presence of these
isotopes in the molecule. This would appear to conflict with the results obtained
by Rubini et al. (1962), who suggested that the inhibition oftheuptake of3H-TdR
by chronic myeloid leukaemic leucocytes and dog bone marrow cells might be due
to thepresenceof3H in thethymidine. The fact thatpre-incubation with 'H-TdR
did not affect the subsequent incorporation of 3H-TdR led Rubini et al. (1962) to
suggest this possible inhibitory action of tritium itself. The current experiments
indicate that this inhibition can beexplained on the basis ofdegradation ofthymi-
dine (see Fig. 4). Furthermore the addition of more 3H-TdR or 3H-dCMP to cells
already showing an inhibition of the incorporation of 3H-TdR was accompanied
by a further incorporation of these precursors into the DNA which indicates that
there is no inhibition ofDNA synthesis.
The degradation of thymidine gives rise to a production of thymine and
dihydrothymine, which are not available as DNA precursors (Friedkin, Tilson and
Roberts, 1956). On the other hand, the degradation ofdCMP leads to theproduc-
tionofdeoxycytidine andthendeoxyuridine bothofwhichcompounds areavailable
for DNA synthesis. That part of the dCMP that is not deaminated acts as a pre-
cursor for DNA cytosine. The deaminated molecule (deoxyuridine) can, after
phosphorylation and methylation, form thymidine monophosphate and act as a
precursor for DNA thymine (Friedkin and Roberts, 1956). The phosphorolysis of
deoxyuridine to uracil is a relatively slow process in the leucocyte incubations
compared with the rapid phosphorolysis ofthymidine by these cells. Analysis of
the bases fromleucocytes incubated with 3H-dCMP suggests that the deamination
of the molecule and the subsequent incorporation of the labeRed pyrimidine into
the DNA thymine is the predominant pathway. It is of interest to note that in
both the degradation ofthymidine and the degradation of dCMP the rates of the
degradation of both these molecules was considerably less in lymphatic cells
compared with ceR suspensions containinggranulocytes. No relation was detected
between the iiumbers of proliferating cells in the suspensions and the rates of
degradation of these compounds. The observations on dCMP deaminase activity in whole leucocytes in vitro are partially in agreement with the findings ofSilber,
Gabrio and Huennekens (1963) who found that dCMP deaminase activity was not
significantly different in homogenates of normal leucocytes and leucocytes of
myeloid and lymphatic leukaemia. We find that lymphatic leukaemic whole
leucocytes have a lower deaminase activity.
The apphcation of the differences in the metabohsm of dCMIP and TdR are
illustrated inFig. I and Tables I and III. Deoxycytidinemonophosphate acts as a
satisfactory source of 3H-pyrimidines for DNA synthesis during the course of a
long incubation (up to 4 hours). The rapid destructionof 3H-TdR precludes its
use as a source ofcontinuous DNA labelling over a period of a few houxs. Cooper, Milton and Hale (1964) in their recent studies ofthe kinetics oftheproliferation of
atypical lymphocytes in infectious mononucleosis observed that 3H-TdR was
unsatisfactorv as a DNA label when the induction of ceRs into DNA s nthesis was y712 E. H. COOPER AND J. D. MILTON
being studied and found 3H-dCMP to be a suitable DNA label to use for this pur-
pose. However, after allowing for differences in specific activity, it is found that
the initial rate ofincorporation of 3H-TdR into DNA is greater than that of the
3H-dCMP. Repeated fractional doses of3H-TdR were found to be a more effective
way oflabelhng the DNA compared with the same total dose given at one time.
When 3H-dCMP was tested in this way the results were variable and probably
reflect the relative predominance of different factors in pathways ofdegradation
and synthesis in the two different cell samples tested.
For manytypes ofkinetic studies it is desirable to have a continuous source of
radioactive precursor in the medium so that the flux of cells from G, into 8 can be
studied (Lamerton and Fry, 1963). The results obtained in this present series of
experiments indicate that very n-iisleading interpretations can be put upon the
data arising from the incorporation of a DNA precursor into both leukaemic and
non leukaemic leucocytes, unless the fate of that precursor in the particular cell
system is known.
SUMMARY
The incorporation of TdR and dCMP into the DNA of humaii leucocytes in
vitro has been studied and an inhibition of TdR incorporation was found com-
pared with the incorporation of dCMP when the cells were incubated with these
precursors for more than one hour. The degradationproducts ofTdR arethymine and dihydrothymine which are not available for DNA synthesis. Degradation of
dCMP leads to the formation ofdeoxycytidine, deoxyuridine and uracil of which
only uracil does not serve as a DNA precursor. The rate of degradation of TdR
and dCMP were more rapid with myeloid cells compared to lymphoid cells. The
reactionisindependent ofthe numbers ofDNAsynthesising cells in the cell suspen- sion. The formation ofuracil from dCMP takesplace more slowly than the forma-
tion of thymine from TdR, thus dCMP provides a longer lasting source of DNA
precursor for prolonged studies of DNA synthesis by leucocytes in vitro.
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